Discover
ELAN
Elanco Animal Health Incorporated
24.09
700 x undefined
300 x undefined
bid
ask
-
0.52
2.11%
500 @ 06:10 AM
24.07 -0.02 (0.08%)
| Ytd | 6.45% | |
| 1y | 66.94% |
24.05
day range
25.20
13.39
52 week range
27.72
| Open | 24.36 | Prev Close | 24.61 | Low | 24.05 | High | 25.20 | Mkt Cap | 12.03B |
| Vol | 3.40M | Avg Vol | 5.78M | EPS | -0.50 | P/E | N/A | Forward P/E | 20.27 |
| Beta | 1.70 | Short Ratio | 5.46 | Inst. Own | 111.33% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-06 | 50-d Avg | 23.08 | 200-d Avg | 22.85 | 1yr Est | 29.86 |
| Income Statement | |||
| Total Revenue | 1.37B | ||
| Revenues (USD) | 1.37B | ||
| Cost of Revenue | 586.00M | ||
| Gross Profit | 785.00M | ||
| Operating Expenses | 632.00M | ||
| Research and Development Expense | 97.00M | ||
| Selling, General and Administrative Expense | 381.00M | ||
| Operating Income | 153.00M | ||
| Interest Expense | 57.00M | ||
| Income Tax Expense | 30.00M | ||
| Net Income | 57.00M | ||
| Net Income Common Stock | 57.00M | ||
| Net Income Common Stock (USD) | 57.00M | ||
| Consolidated Income | 57.00M | ||
| Earnings per Basic Share | 0.11 | ||
| Earnings per Basic Share (USD) | 0.11 | ||
| Earnings per Diluted Share | 0.11 | ||
| Earning Before Interest & Taxes (EBIT) | 144.00M | ||
| Earning Before Interest & Taxes (USD) | 144.00M | ||
| Weighted Average Shares | 497.70M | ||
| Weighted Average Shares Diluted | 506.00M | ||
| Balance Sheet | |||
| Cash and Equivalents | 428.00M | ||
| Cash and Equivalents (USD) | 428.00M | ||
| Trade and Non-Trade Receivables | 1.15B | ||
| Current Assets | 3.58B | ||
| Property, Plant & Equipment Net | 1.40B | ||
| Total Assets | 13.22B | ||
| Debt Current | 73.00M | ||
| Total Debt | 4.30B | ||
| Current Liabilities | 1.66B | ||
| Debt Non-Current | 4.23B | ||
| Total Liabilities | 6.72B | ||
| Accumulated Retained Earnings (Deficit) | -2.12B | ||
| Accumulated Other Comprehensive Income | -233.00M | ||
| Shareholders Equity | 6.50B | ||
| Shareholders Equity (USD) | 6.50B | ||
| Assets Non-Current | 9.64B | ||
| Total Debt (USD) | 4.30B | ||
| Goodwill and Intangible Assets | 7.95B | ||
| Inventory | 1.72B | ||
| Liabilities Non-Current | 5.06B | ||
| Trade and Non-Trade Payables | 372.00M | ||
| Tax Liabilities | 366.00M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 172.00M | ||
| Net Cash Flow from Financing | -65.00M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -117.00M | ||
| Capital Expenditure | -51.00M | ||
| Issuance (Purchase) of Equity Shares | -34.00M | ||
| Issuance (Repayment) of Debt Securities | -16.00M | ||
| Net Cash Flow from Investing | -60.00M | ||
| Net Cash Flow from Operations | 13.00M | ||
| Effect of Exchange Rate Changes on Cash | -5.00M | ||
| Share Based Compensation | 21.00M | ||